Selling or partnering your beauty brand or contract manufacturer: a selective market with many buyers

For decades, French beauty was handed on within the industry: a family laboratory passed to the next generation, a niche brand was taken over by a distributor or a peer, a contract manufacturer was sold to its main customer. Those days are over: the giants seek growth in independent brands, funds have understood the recurring revenue of contract manufacturing, and deals between mid-sized players have multiplied.

The 2026 context adds pressure. French cosmetics exports fell in 2025 for the first time since the 2008 crisis, excluding the pandemic, under the effect of US tariffs. ¹ European regulation is increasing fixed costs, and the merger talks between The Estée Lauder Companies and Puig revealed in March 2026 show that concentration is reaching the top of the pyramid. ² For an independent owner, the question is no longer whether buyers exist, but where their company stands in a market that is sorting.

A powerful, export-driven industry made up of SMEs

Beauty is the second-largest contributor to the French trade balance, with a surplus of €17.3 billion in 2024, behind aerospace, according to the French Treasury. ³ In 2025, exports reached €22.4 billion against €22.5 billion the previous year, according to the industry federation FEBEA: a stagnation that hides a fall of around 19% to the United States, offset by 4% growth to the European Union, which now accounts for more than half of sales abroad. ¹ Make-up and facial care make up nearly half of exports, fragrance more than a third. ¹ At European level, Cosmetics Europe puts the retail market at €110 billion in 2025 and exports at €29.8 billion, with France and Spain together accounting for nearly half of European sales to the rest of the world. ⁴

Behind the big names, the industry is made of SMEs. The Cosmetic Valley cluster counts more than 6,300 establishments and nearly 226,000 jobs, around 85% of them in micro-businesses, SMEs and mid-caps; FEBEA cites nearly 300,000 direct and indirect jobs, and 82% of its members are micro-businesses or SMEs. ^1,5,6 The industrial upstream, meaning subcontractors, mould makers and packaging producers, is 85% SMEs and mid-caps. ⁶ This fabric is the sector's pool of transactions.

The drivers of consolidation

The reversal in US exports. Since 1 August 2025, most French fragrances and cosmetics entering the United States have been subject to 15% tariffs. ³ Sales to this market lost more than €500 million in 2025 and a further fall is considered likely for 2026. ¹ Large groups built up inventory and absorbed part of the shock; an independent brand making a third of its sales across the Atlantic does not have that latitude. ³
European regulatory inflation. The Packaging and Packaging Waste Regulation (PPWR), the revision of the Cosmetics Regulation, PFAS restrictions and the Urban Wastewater Treatment Directive are all arriving at once. The industry estimates the cost of the latter at €513 to €633 million a year for the cosmetics and pharmaceutical industries, and 92% of companies surveyed face packaging compliance problems. ⁶ Each new obligation is a fixed cost that a ten-person company cannot amortise like a thousand-person one.
Groups' demand for established brands. Building a brand from scratch is long and expensive; buying one that already has its community and distribution is faster, especially in the niches driving the market: dermocosmetics, haircare, niche fragrance, premium products or clean formulations. L'Oréal took over Kering's beauty division in autumn 2025, Estée Lauder takes minority stakes in niche perfumers through its incubation arm, and the consultancy Kearney expects beauty M&A to rise through 2027. ²
Funds entering contract manufacturing. Contract manufacturing and packaging offer multi-year contracts, a client base of large groups and growth driven by outsourcing. Weinberg Capital Partners' investment in Cosmogen at the end of 2024, with a roadmap focused on external growth, or the €15 million invested by Superga Beauty in Reims, illustrate this logic of platforms growing through acquisitions. ^7,8
The cost of digital marketing and channel convergence. Online acquisition costs have risen sharply, and a brand must now be present on its own site, marketplaces, pharmacies, specialist retail or salons at once. Pooling content, influencer marketing, customer data and omnichannel logistics is within reach of a group or multi-brand platform, much less of a standalone brand.
The cost of tools and generational renewal. Ingredient traceability, direct online sales, customer data: investments have changed scale. Many regional laboratories and contract manufacturers were founded in the 1980s and 1990s by founders approaching succession, often without a family successor.

Who buys brands and subcontractors today

Large beauty and luxury groups. L'Oréal, Estée Lauder, Puig, LVMH, Coty or pharmaceutical laboratories active in dermocosmetics buy brands with international potential, complementary categories or differentiating technologies, often in two stages: a minority first, then control.
Multi-brand platforms. Backed by funds or families, they bring together several independent brands to pool distribution, marketing, finance and international expansion, often keeping the founder as a partner and at the head of their brand.
Fund-backed industrial platforms. Contract manufacturers, applicator and packaging makers, formulation laboratories: funds build multi-site groups through successive acquisitions, following a buy-and-build logic, in search of complementary capacity or a geographic footprint.
Growing mid-caps, peers and contract manufacturers, often family-owned, that buy laboratories or regional brands to complete their ranges, acquire a formulation technology or secure know-how; consumer goods groups also enter beauty through brands with a strong community.
Foreign buyers. Italian, Spanish, American, Korean or Gulf groups: the reputation of French manufacturing is a selling point in itself. For salons and institutes, buyers are mainly organised networks seeking locations and trained teams.

The sector imposes no restrictions on capital ownership, but it has its checkpoints. The responsible person under the EU Cosmetics Regulation, product information files, registered trademarks and formulas, and good manufacturing practice certifications are attached to specific legal entities: a buyer checks that they are held by the company being sold and will survive the change of control.

What this changes for the owner

A full sale suits a founder who wants to hand over to a group able to take the brand or plant further, with a transition of a few months to two years.
A partnership with reinvestment is for an owner who wants to secure part of their wealth while continuing to grow: they sell a majority or a minority, reinvest part of the price in the acquisition holding and share in the next round of value creation.
A combination between peers of comparable size, for example a formulation laboratory and a contract manufacturer, reaches critical mass with clients and regulatory obligations without an outside investor.
A capital reorganisation such as an OBO lets the founder monetise part of their shares and bring in the management team, with bank debt or a minority investor, while keeping control.

In all cases, buyers look at the same things, and growth alone is not enough: they want to understand the quality of the brand or order book, the margin once marketing is paid, and the ability to repeat growth beyond a single channel, hero product or dominant customer.

Brand strength. Awareness, community, repurchase rate, customer reviews and the share of demand that arrives without advertising spend distinguish an established brand from one carried by its campaigns.
Economics by channel and country. Margin, acquisition cost, returns, promotions and the contribution of each channel (own site, marketplaces, pharmacy, retail, export) must be readable, as must the geographic split of sales in the era of US tariffs.
Product and customer concentration. For a brand, dependence on a best-seller with no innovation pipeline; for a subcontractor, the share of one or two clients and the length of manufacturing contracts.
Intellectual property and regulatory files. Trademarks and formulas registered in the name of the company being sold, product information files, claims, the responsible person and PPWR and PFAS compliance are checked before any binding offer.
The industrial base and supply chain. Good manufacturing practice certifications, condition of the lines, available capacity, critical suppliers, minimum order quantities, inventory levels and lead times determine the scale-up capacity the buyer is purchasing.
Real profitability. Once marketing spend is normalised and exceptional launches adjusted, recurring margin by range or customer is the basis for discussion.
The team. Management able to carry formulation, relationships with distributors or clients and regulatory compliance counts as much as the figures.

You are thinking of selling: is this the right moment for you?

This is the first question we ask, and the answer is not the same for everyone. The right moment is never automatically "right now", even in a market where buyers remain numerous. It depends on two things: you, meaning your life plans, personal horizon and wealth objectives, and your company, meaning its ability to realise today all the value it holds. We encounter two situations.

Your company is almost ready. Growth is steady and does not depend on disproportionate marketing spend, customers or channels are diversified, regulatory files are up to date, margin is readable. For a contract manufacturer, this is often the moment when commercial visibility is strong and there is still capacity to offer the buyer. Or you want your brand or laboratory to become part of a larger project, that of a large group, often under LBO, that brings the tools, expertise and resources to absorb the changes in the sector, which is reassuring for you and for your teams. A few weeks of preparation are then enough to go to market, and the large number of buyers works in your favour.
Your company needs time. One or two clients account for most of your revenue, the year's margin was eroded by falling US sales, the compliance of packaging or formulas with the new European texts has not been started. Selling remains possible, but it means accepting a discount. We will then tell you frankly that it is better to spend several months, sometimes a few years, working on these points, and we can support you through that phase before launching the transaction when you are truly ready.

The workstreams that make the difference are well known: segment sales by product, channel, country and customer cohort and link them to margin and marketing spend, diversify customers or sales channels, secure ownership of formulas and trademarks, anticipate PPWR and PFAS compliance rather than suffer it, formalise subcontracting contracts and their terms, put inventory and the launch calendar in order, and show profitability by range or customer. Depending on your starting point, they take a few weeks or a few years.

The benefit of talking early, even without being sure you want to sell, is precisely knowing which of these two situations you are in, and deciding with full knowledge rather than under the pressure of a client bringing production back in-house or an unexpected approach.

Facing groups with dedicated acquisition teams and funds that complete several deals a year, a founder negotiating alone is rarely on an equal footing. The value of a brand or laboratory is not just a headline price: it depends on the buyer's plan, the price structure, any earn-out linked to future sales, the share reinvested, the warranties, and the future of the teams and sites. Two offers for the same amount can mean very different things.

The role of an independent M&A adviser is to establish an objective valuation, identify all relevant buyers, in France and abroad, put them in competition in a structured and confidential process, and negotiate beyond price alone. This competition protects the seller: it lets them compare genuinely different projects and choose the one that fits their objectives and their teams.

Frequently asked questions

Which beauty companies interest buyers today?

Differentiated cosmetics brands with a loyal community and a high repurchase rate, laboratories and contract manufacturers with formulation know-how or certified industrial capacity, packaging and applicator makers, and more broadly any company that holds a channel, a technology or a client base that is hard to reproduce. Niches such as dermocosmetics, haircare and niche fragrance are particularly sought after.

Who buys cosmetics brands and subcontractors?

Large beauty and luxury groups such as L'Oréal, Estée Lauder, Puig or LVMH, which buy brands with international potential, often in two stages; multi-brand and industrial platforms backed by investment funds; family mid-caps and peers completing their ranges or capacity; and foreign buyers attracted by the reputation of French manufacturing.

Is e-commerce enough to make a beauty brand attractive?

No. Strong online growth is only worth something if it comes with a positive margin once acquisition costs are paid, a solid repurchase rate and the ability to exist in other channels, pharmacy, specialist retail or export. Buyers are wary of growth bought through advertising and look first at the share of demand that arrives organically.

Can you sell your cosmetics brand and stay at the helm?

Yes, it is even the most common structure for a founder. In a partnership, they sell a majority or a minority to a group or multi-brand platform, reinvest part of the price and continue to run the brand with greater resources for international expansion, retail or innovation, sharing in the next round of value creation.

Is an approval required to buy a cosmetics laboratory?

No, the sector imposes no restrictions on capital ownership. However, the EU Cosmetics Regulation attaches obligations to specific entities: the responsible person, product information files, registered trademarks and formulas and good manufacturing practice certifications must be held by the company being sold and survive the change of control, which the buyer checks during due diligence.

How long does it take to sell a beauty brand or contract manufacturer?

Between preparing the file and signing, generally six to nine months, the time needed to confidentially approach buyers in France and abroad, gather offers, carry out regulatory, industrial and financial due diligence, then negotiate. Upstream preparation, notably regulatory compliance and segmenting sales by channel, can take several more months.

When should you start preparing the sale of your cosmetics company?

Ideally two to three years before the target date, to have time to diversify channels or clients, secure intellectual property, anticipate the compliance of packaging and formulas with the new European regulations and show profitability by range. Demonstrating a margin preserved despite falling US sales is a decisive asset today.

Why put several buyers in competition to sell your brand?

Because groups and funds complete several deals a year and know market prices and clauses, which is not the case for a founder who sells once. A confidential process bringing together French and foreign candidates allows you to compare prices, but also the plan for the brand, the earn-out linked to future sales, the share reinvested, warranties and the future of the teams and sites.

Public sources consulted

FEBEA, communiqué de presse, Exportations de cosmétiques français en 2025 (6 février 2026) : https://www.febea.fr/sites/default/files/2026-02/CP%20FEBEA%20Export%202025.pdf (high reliability)
Journal du Luxe, The Estée Lauder Companies et Puig : vers une fusion des deux géants de la beauté de prestige (24 mars 2026) : https://www.journalduluxe.fr/fr/beaute/estee-lauder-cie-puig-annonce-projet-fusion-beaute-prestige (good reliability)
Direction générale du Trésor, Flash conjoncture France, Les exportations cosmétiques françaises face aux droits de douane américains (17 octobre 2025) : https://www.tresor.economie.gouv.fr/Articles/2025/10/17/flash-conjoncture-france-les-exportations-cosmetiques-francaises-face-aux-droits-de-douanes-americains (high reliability)
Cosmetics Europe, Our Industry, chiffres 2025 (consulté en octobre 2026) : https://cosmeticseurope.eu/our-industry/ (good reliability)
Cosmetic Valley, communiqué de presse, Cosmetic Valley accueille 21 nouveaux adhérents (24 avril 2024) : https://www.cosmetic-valley.com/sites/default/files/press_release/file/COSMETIC%20VALLEY%20ACCUEILLE%2021%20NOUVEAUX%20ADHE%CC%81RENTS.pdf (good reliability)
FEBEA, communiqué de presse, Sixième Comité de filière cosmétique à Bercy (3 février 2026) : https://www.febea.fr/sites/default/files/2026-02/CP%20Comite%20de%20filiere%20cosme%CC%81tique%202026_0.pdf (high reliability)
Premium Beauty News, Avec Weinberg Capital Partners, Cosmogen accélère à l'international et prépare des acquisitions (10 décembre 2024) : https://www.premiumbeautynews.com/fr/avec-weinberg-capital-partners,24926 (good reliability)
Premium Beauty News, Superga Beauty investit 15 millions d'euros pour transformer son site de Reims (6 octobre 2026) : https://www.premiumbeautynews.com/fr/superga-beauty-investit-15,28306 (good reliability)